重症监护疾病后显著持续性疼痛症状的患病率与危险因素:一项前瞻性多中心研究
该前瞻性多中心研究纳入ICU停留≥48小时的814例患者,主要终点为入ICU后3个月显著持续性疼痛(NRS≥3)的患病率。3个月时388例(47.7%)存在显著疼痛,其中34例(8.7%)有神经病理性疼痛症状。女性(OR 1.5,95%CI 1.1-2.1)、既往使用抗抑郁药(OR 2.2,95%CI 1.3-4)、俯卧位(OR 3,95%CI 1.4-6.4)、ICU出院时存在疼痛症状(NRS≥3)(OR 2.4,95%CI 1.7-3.4)及因非神经性创伤入院(OR 3.5,95%CI 2.1-6)为持续性疼痛的危险因素。仅35例(11.3%)在3个月内接受专科疼痛管理。
要点
- ICU停留≥48小时的存活者中,入ICU后3个月显著持续性疼痛(NRS≥3)的患病率为47.7%(388/814)。
- 持续性疼痛的危险因素包括女性(OR 1.5,95%CI 1.1-2.1)、既往使用抗抑郁药(OR 2.2,95%CI 1.3-4)、俯卧位(OR 3,95%CI 1.4-6.4)、ICU出院时疼痛NRS≥3(OR 2.4,95%CI 1.7-3.4)。
- 与脓毒症相比,因非神经性创伤入院的患者持续性疼痛风险更高(OR 3.5,95%CI 2.1-6)。
- 3个月时仅35例(11.3%)患者接受了专科疼痛管理,专科管理仍不频繁。
- 3个月时全体人群中位疼痛强度为2分(四分位间距1-5),显著疼痛患者中34例(8.7%)存在神经病理性疼痛症状(ID-pain评分>3)。
适用人群与场景
- ICU停留时间≥48小时的重症患者,来自26个中心、10个月期间纳入的814例患者。
- 平均年龄57(±17)岁,SAPS 2评分32(±16)(均值±标准差),中位ICU停留时间6天(四分位间距4-12天)。
诊断标准与关键阈值
- 显著持续性疼痛定义为入ICU后3个月时数字评定量表(NRS)≥3分。
- 神经病理性疼痛症状定义为ID-pain评分>3分。
研究设计与关键结果
- 研究类型:前瞻性多中心研究,纳入26个中心、814例ICU停留≥48小时的患者,纳入期间为10个月。
- 主要终点:入ICU后3个月时,388例(47.7%)患者存在显著持续性疼痛(NRS≥3);全体人群中位疼痛强度为2分(四分位间距1-5)。
- 次要终点:显著疼痛患者中34例(8.7%)存在神经病理性疼痛症状(ID-pain评分>3)。
- 危险因素:女性OR 1.5(95%CI 1.1-2.1);既往使用抗抑郁药OR 2.2(95%CI 1.3-4);俯卧位OR 3(95%CI 1.4-6.4);ICU出院时存在疼痛症状(NRS≥3)OR 2.4(95%CI 1.7-3.4);与脓毒症相比,因非神经性创伤入院OR 3.5(95%CI 2.1-6)。
- 疼痛管理:至3个月时仅35例(11.3%)患者接受了专科疼痛管理。
证据类型、等级与局限
- 证据类型:前瞻性多中心研究。
- 试验注册号:NCT04817696,注册日期2021年3月26日。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,重症监护存活者中持续性疼痛症状常见,而专科疼痛管理仍不频繁,需要在ICU中开发创新方法以尽量减少疼痛的后果。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Prevalence, risk factors and medical management of persistent pain symptoms after critical care illness have not been thoroughly investigated.
METHODS: We performed a prospective multicentric study in patients with an intensive care unit (ICU) length of stay ≥ 48 h. The primary outcome was the prevalence of significant persistent pain, defined as a numeric rating scale (NRS) ≥ 3, 3 months after admission. Secondary outcomes were the prevalence of symptoms compatible with neuropathic pain (ID-pain score > 3) and the risk factors of persistent pain.
RESULTS: Eight hundred fourteen patients were included over a 10-month period in 26 centers. Patients had a mean age of 57 (± 17) years with a SAPS 2 score of 32 (± 16) (mean ± SD). The median ICU length of stay was 6 [4-12] days (median [interquartile]). At 3 months, the median intensity of pain symptoms was 2 [1-5] in the entire population, and 388 (47.7%) patients had significant pain. In this group, 34 (8.7%) patients had symptoms compatible with neuropathic pain. Female (Odds Ratio 1.5 95% CI [1.1-2.1]), prior use of anti-depressive agents (OR 2.2 95% CI [1.3-4]), prone positioning (OR 3 95% CI [1.4-6.4]) and the presence of pain symptoms on ICU discharge (NRS ≥ 3) (OR 2.4 95% CI [1.7-3.4]) were risk factors of persistent pain. Compared with sepsis, patients admitted for trauma (non neuro) (OR 3.5 95% CI [2.1-6]) were particularly at risk of persistent pain. Only 35 (11.3%) patients had specialist pain management by 3 months.
CONCLUSIONS: Persistent pain symptoms were frequent in critical illness survivors and specialized management remained infrequent. Innovative approaches must be developed in the ICU to minimize the consequences of pain.
TRIAL REGISTRATION: NCT04817696. Registered March 26, 2021.
参考来源
- Bourdiol A, Legros V, Vardon-Bounes F, et al. Prevalence and risk factors of significant persistent pain symptoms after critical care illness: a prospective multicentric study. Crit Care. 2023. PMID: 37226261. doi:10.1186/s13054-023-04491-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。